Skip to Main Content

Paper Details

Efficacy and safety of monotherapy with enavogliflozin in Korean patients with type 2 diabetes mellitus: Results of a 12-week, multicentre, randomized, double-blind, placebo-controlled, phase 2 trial.
2
2023
Author NameAffiliation
Kyong Soo ParkSeoul National University Hospital, Seoul National University College of Medicine
  • 1 - 1

Datasets

Release 1.2